Invention Grant
- Patent Title: Quinolinyloxyphenylsulfonamides
- Patent Title (中): 喹啉氧基苯磺酰胺
-
Application No.: US13500761Application Date: 2010-10-16
-
Publication No.: US08685971B2Publication Date: 2014-04-01
- Inventor: Axel Ullrich , Robert Torka , Yixiang Zhang , György Kéri , László Örfi , István Szabadkai
- Applicant: Axel Ullrich , Robert Torka , Yixiang Zhang , György Kéri , László Örfi , István Szabadkai
- Applicant Address: DE München
- Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Current Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Current Assignee Address: DE München
- Agency: Meyertons, Hood, Kivlin, Kowert & Goetzel, P.C.
- Agent Eric B. Meyertons
- Priority: EP09075468 20091016
- International Application: PCT/EP2010/006525 WO 20101016
- International Announcement: WO2011/045084 WO 20110421
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4709 ; A61K31/496 ; A61K31/5375 ; A61P35/00 ; C07D215/233 ; C07D401/12 ; C07D401/14 ; C07D405/12 ; C07D409/14 ; C07D413/12
Abstract:
The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.
Public/Granted literature
- US20120277231A1 QUINOLINYLOXYPHENYLSULFONAMIDES Public/Granted day:2012-11-01
Information query
